The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT05676476
Status
Recruiting
Apply to this trial

Conditions

  • Gestational Hypertension
  • Hypertensive Disorder of Pregnancy
  • Preeclampsia

Eligibility Criteria

Sex
FEMALE
Age
14 Years - 49 Years
Healthy Volunteers
Not accepted

Interventions

  • Antihypertensive treatment — DRUG
    Antihypertensive treatment to goal of less than 140/90 mmHg

Study Details

The Achieve Trial is a randomized clinical trial to test whether lowering blood pressure to less than 140/90 mmHg in women with hypertensive disorders of pregnancy will prolong pregnancy.

Key Dates

Start date
Feb 14, 2023
Status verified
Dec 2025
Primary completion
Dec 31, 2026
Completion
Jun 30, 2027

Study Design

Enrollment
132 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    Antihypertensive treatment for a BP goal of less than 140/90 mmHg
  • No Intervention: Usual Care
    Antihypertensive treatment only if BP ≥ 160/110 mmHg

Primary Outcome Measure

Mean number of days from randomization to delivery [ Time Frame: From randomization to delivery, up to 14 weeks ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35233
Rachel Sinkey
[email protected]
2059345611
OschnerNew OrleansLouisiana70115
Sherri Longo, MD
[email protected]
504-842-4151

Find similar trials in Birmingham, AL

By research site
University of Alabama at Birmingham· Birmingham, ALOschner· New Orleans, LA

Related Studies